Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2687922

CC(C)C(=O)OC(C)(C)C.N

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.37
CA14 Q9ULX7 1/20 0.37
DGAT1 O75907 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 1/20 0.36
NOS1 P29475 2/20 0.35
NOS3 P29474 1/20 0.35
NOS2 P35228 1/20 0.35
CYP2D6 P10635 1/20 0.32
APP P05067 1/20 0.32
MEN1 O00255 2/20 0.31
GAA P10253 1/20 0.31
ELANE P08246 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL108717 0.97 DGAT1 (0.39) CA12CA14DGAT1CA1CA2
Hydrogen Peroxide SCHEMBL22069989 0.94 CA12 (0.37) CA12CA14DGAT1CA1CA2
Hydrogen Peroxide SCHEMBL28045178 0.94 CA12 (0.37) CA12CA14DGAT1CA1CA2
Water SCHEMBL27826633 0.94 CA12 (0.37) CA12CA14DGAT1CA1CA2
SCHEMBL8651672 0.94 CA12 (0.37) CA12CA14DGAT1CA1CA2
Hydrochloric Acid SCHEMBL4310897 0.94 CA12 (0.37) CA12CA14DGAT1CA1CA2
Nitrogen SCHEMBL28125054 0.92 CA12 (0.36) CA12CA14DGAT1CA1CA2
Methane SCHEMBL28765863 0.92 CA12 (0.36) CA12CA14DGAT1CA1CA2
Methylene Chloride SCHEMBL28765862 0.87 CA1 (0.37) CA12CA14DGAT1CA1CA2
SCHEMBL27664366 0.84 CA1 (0.35) CA12CA14DGAT1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829035-B2 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-09-09 US disclosed
EP-2436683-B1 AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS SUMITOMO CHEMICAL CO (JP) 2014-05-14 EP disclosed
US-20120115856-A1 AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-10 US disclosed
CN-102428080-A Therapeutic or prophylactic agent for diseases in which neurotrophic factor activity participates SUMITOMO CHEMICAL CO 2012-04-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115856-A1 AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS BDNF, NGF, NTRK2 CA12 1790/4885CA14 1688/4885DGAT1 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.